Bemærk at denne jobannonce er udløbet!
Ansøgningsfristen for jobannoncen er overskredet, og stillingen kan ikke længere søges. Opslaget vises udelukkende som reference

PhD Project on Molecular Characterization of Atopic Dermatitis

About this project

Atopic dermatitis (AD) is a chronically relapsing, inflammatory skin disease, which affects 2-5% of the adult population and 10-20% of children worldwide.

Treatment of AD is symptomatic and is generally considered unsatisfactory with limited efficacy. This stems in large part from an incomplete understanding of the multifactorial pathogenesis of AD, involving environmental, genetic and immunologic factors. Therefore, although AD is commonly described as a single disease, its complexity suggests a need for better classification into specific disease subtypes (endotypes), each associated with distinct underlying molecular mechanisms and treatment responses. It is such an in-depth characterization, enabling a full molecular understanding of the endotypes of AD, which is the main aim of the current project. Thus, we expect to identify biomarkers of AD that will a) improve differential diagnosis of AD, b) increase our molecular understanding of AD pathogenesis, and c) accelerate development of novel, pathway-directed therapeutic approaches.

Specifically, we will employ an integrative, systems biology approach by extensive, cellular and molecular profiling of patient skin, blood and urine using cutting edge technologies, including genomics, next-generation sequencing, metabolomics, microbiome analysis, highly sensitive immunoassays and state of the art bioinformatics.

It will be the first investigation of its kind that incorporates cellular and molecular biomarkers of both lesional and non-lesional skin and of systemic inflammation as a function of time and place to fully characterize AD patients based on disease severity and phenotypes. Our ambition is to obtain a comprehensive understanding of the molecular features of the endotypes of AD. Such an understanding will pave the way for development of new and improved treatments.

Job description

The successful candidate will be in charge of managing, integrating, analyzing and reporting on the data generated in the project. Additional tasks include: participation in relevant PhD courses and dissemination of your research at meetings and international congresses.

Qualifications

  • A completed masters degree in bioinformatics, computer science, statistics or another relevant area
  • Experience with integrative methods for analysis of multi-dimensional data
  • Strong statistical skills, including experience in the scripting language R
  • Good knowledge of cellular and molecular biology
  • Proficiency in English, both in writing and speech

It will be an advantage if you

  • are self-motivated, have strong analytical skills, and a focused approach to problem solving
  • thrive with high expectations, independence, and substantial responsibility
  • have worked with transcriptomics data, such as RNA-seq
  • have programming experience, e.g. in Python or R
  • have excellent interpersonal skills
  • love data 

The position is available from Sep 1 or by appointment

Applications including a short CV should be sent to: Thomas Litman, TYLDK@leo-pharma.com

To learn more about the position, please contact: Thomas Litman, CEL +45 4185 1753

Location: LEO Pharma, Industriparken 55, 2750 Ballerup, Denmark.


Mere af samme slags?

Angiv din e-mail og få lignende job direkte i indbakken




Når du tilmelder dig accepterer du samtidig vores privativspolitik

330028597Phoenix-fd1b815c12019-06-03T00:00:00PhD Project on Molecular Characterization of Atopic Dermatitis

About this project

Atopic dermatitis (AD) is a chronically relapsing, inflammatory skin disease, which affects 2-5% of the adult population and 10-20% of children worldwide.

Treatment of AD is symptomatic and is generally considered unsatisfactory with limited efficacy. This stems in large part from an incomplete understanding of the multifactorial pathogenesis of AD, involving environmental, genetic and immunologic factors. Therefore, although AD is commonly described as a single disease, its complexity suggests a need for better classification into specific disease subtypes (endotypes), each associated with distinct underlying molecular mechanisms and treatment responses. It is such an in-depth characterization, enabling a full molecular understanding of the endotypes of AD, which is the main aim of the current project. Thus, we expect to identify biomarkers of AD that will a) improve differential diagnosis of AD, b) increase our molecular understanding of AD pathogenesis, and c) accelerate development of novel, pathway-directed therapeutic approaches.

Specifically, we will employ an integrative, systems biology approach by extensive, cellular and molecular profiling of patient skin, blood and urine using cutting edge technologies, including genomics, next-generation sequencing, metabolomics, microbiome analysis, highly sensitive immunoassays and state of the art bioinformatics.

It will be the first investigation of its kind that incorporates cellular and molecular biomarkers of both lesional and non-lesional skin and of systemic inflammation as a function of time and place to fully characterize AD patients based on disease severity and phenotypes. Our ambition is to obtain a comprehensive understanding of the molecular features of the endotypes of AD. Such an understanding will pave the way for development of new and improved treatments.

Job description

The successful candidate will be in charge of managing, integrating, analyzing and reporting on the data generated in the project. Additional tasks include: participation in relevant PhD courses and dissemination of your research at meetings and international congresses.

Qualifications

  • A completed masters degree in bioinformatics, computer science, statistics or another relevant area
  • Experience with integrative methods for analysis of multi-dimensional data
  • Strong statistical skills, including experience in the scripting language R
  • Good knowledge of cellular and molecular biology
  • Proficiency in English, both in writing and speech

It will be an advantage if you

  • are self-motivated, have strong analytical skills, and a focused approach to problem solving
  • thrive with high expectations, independence, and substantial responsibility
  • have worked with transcriptomics data, such as RNA-seq
  • have programming experience, e.g. in Python or R
  • have excellent interpersonal skills
  • love data 

The position is available from Sep 1 or by appointment

Applications including a short CV should be sent to: Thomas Litman, TYLDK@leo-pharma.com

To learn more about the position, please contact: Thomas Litman, CEL +45 4185 1753

Location: LEO Pharma, Industriparken 55, 2750 Ballerup, Denmark.

2019-07-01T00:51:31.527 About this project Atopic dermatitis (AD) is a chronically relapsing, inflammatory skin disease, which affects 2-5 of the adult population and 10-20 of children worldwide. Treatment of AD is symptomatic and is generally considered unsatisfactory with limited efficacy. This stems in large part from an incomplete understanding of the multifactorial pathogenesis of AD, involving environmental, genetic and immunologic factors. Therefore, although AD is commonly described as a single disease, its complexity suggests a need for better classification into specific disease subtypes (endotypes), each associated with distinct underlying molecular mechanisms and treatment responses. It is such an in-depth characterization, enabling a full molecular understanding of the endotypes of AD, which is the main aim of the current project. Thus, we expect to identify biomarkers of AD that will a) improve differential diagnosis of AD, b) increase our molecular understanding of AD pathogenesis, and c) accelerate development of novel, pathway-directed therapeutic approaches. Specifically, we will employ an integrative, systems biology approach by extensive, cellular and molecular profiling of patient skin, blood and urine using cutting edge technologies, including genomics, next-generation sequencing, metabolomics, microbiome analysis, highly sensitive immunoassays and state of the art bioinformatics. It will be the first investigation of its kind that incorporates cellular and molecular biomarkers of both lesional and non-lesional skin and of systemic inflammation as a function of time and place to fully characterize AD patients based on disease severity and phenotypes. Our ambition is to obtain a comprehensive understanding of the molecular features of the endotypes of AD. Such an understanding will pave the way for development of new and improved treatments. Job description The successful candidate will be in charge of managing, integrating, analyzing and reporting on the data generated in the project. Additional tasks include: participation in relevant PhD courses and dissemination of your research at meetings and international congresses. Qualifications A completed masters degree in bioinformatics, computer science, statistics or another relevant area Experience with integrative methods for analysis of multi-dimensional data Strong statistical skills, including experience in the scripting language R Good knowledge of cellular and molecular biology Proficiency in English, both in writing and speech It will be an advantage if you are self-motivated, have strong analytical skills, and a focused approach to problem solving thrive with high expectations, independence, and substantial responsibility have worked with transcriptomics data, such as RNA-seq have programming experience, e.g. in Python or R have excellent interpersonal skills love data The position is available from Sep 1 or by appointment Applications including a short CV should be sent to: Thomas Litman, TYLDK@leo-pharma.com To learn more about the position, please contact: Thomas Litman, CEL 45 4185 1753 Location: LEO Pharma, Industriparken 55, 2750 Ballerup, Denmark.11jobnetfd1b815c100000000000IDK_OFIR_02DKDanmark228DKK2019-06-30T00:00:000000https://leopharma.easycruit.com/vacancy/2306043/1275130EuropaDanmarkSjælland & øerStorkøbenhavnBallerupEuropaDanmarkSjælland & øerNordsjællandEgedalEuropaDanmarkSjælland & øerStorkøbenhavnAlbertslund3531350LEO PHARMA A/S11Industriparken 552750BallerupDKDanmark0DKDanmarkDKDanmark8Fuldtid46Permanent764878JobNet4992668499266810021-05-20190https://dispatcher.ofir.dk/statistic/register?context=FeedEntrySearchedCount&feedId=dc2beb84&entryId=fd1b815chttps://dispatcher.ofir.dk/statistic/register?context=FeedEntryDisplayCount&feedId=dc2beb84&entryId=fd1b815chttps://dispatcher.ofir.dk/statistic/register?context=JobApplicationInitiatedCount&feedId=dc2beb84&entryId=fd1b815c&page=ShowJob&component=SendApplicationButtonhttps://dispatcher.ofir.dk/statistic/register?context=JobApplicationAppliedCount&feedId=dc2beb84&entryId=fd1b815c&page=EmailApplyForm&component=SendApplicationButtonPhD Project on Molecular Characterization of Atopic Dermatitis1Dansk3Læse/ tale11007General7Håndværk & service361845000noreply@ofir.comDKDanmarkDKDanmarkda-DK